InvestorsObserver
×
News Home

Should You Buy Cannabis Stock Tilray Inc (TLRY) Wednesday?

Wednesday, March 09, 2022 02:32 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Cannabis Stock Tilray Inc (TLRY) Wednesday?

TLRY stock is higher by 1.98% Wednesday as the cannabis stock increases $0.11 and underperforms the market.The 9 rating InvestorsObserver gives to Tilray Inc (TLRY) stock puts it near the middle of the Healthcare sector. In addition to scoring higher than 64 percent of stocks in the Healthcare sector, TLRY’s 9 overall rating means the stock scores better than 9 of all stocks.

Overall Score - 9
TLRY has an Overall Score of 9. Find out what this means to you and get the rest of the rankings on TLRY!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Tilray Inc Stock Today?

Tilray Inc (TLRY) stock is trading at $5.41 as of 2:19 PM on Wednesday, Mar 9, an increase of $0.11, or 1.98% from the previous closing price of $5.30. The stock has traded between $5.39 and $5.62 so far today. Volume today is below average. So far 12,249,056 shares have traded compared to average volume of 18,461,488 shares. Click Here to get the full Stock Report for Tilray Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App